Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Diffusion-weighted MRI as a biomarker for treatment response in glioma. CNS Oncol 2012 Nov;1(2):169-80 PMID: 23936625 PMCID: PMC3734866

Abstract

Diffusion-weighted imaging (DWI) is a powerful MRI method, which probes abnormalities of tissue structure by detecting microscopic changes in water mobility at a cellular level beyond what is available with other imaging techniques. Accordingly, DWI has the potential to identify pathology before gross anatomic changes are evident on standard anatomical brain images. These features of tissue characterization and earlier detection are what make DWI particularly appealing for the evaluation of gliomas and the newer therapies where standard anatomical imaging is proving insufficient. This article focuses on the basic principles and applications of DWI, and its derived parameter, the apparent diffusion coefficient, for the purposes of diagnosis and evaluation of glioma, especially in the context of monitoring response to therapy.

Author List

Schmainda KM

Author

Kathleen M. Schmainda PhD Professor in the Radiology department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Animals
Brain
Brain Neoplasms
Diffusion Magnetic Resonance Imaging
Glioma
Humans



View this publication's entry at the Pubmed website PMID: 23936625
jenkins-FCD Prod-153 3ca6710ea990189ceb85f4312e7298b5922ce1a6